Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

193 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of mutated, activated BRAF in metastatic melanoma.
Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB. Flaherty KT, et al. Among authors: chapman pb. N Engl J Med. 2010 Aug 26;363(9):809-19. doi: 10.1056/NEJMoa1002011. N Engl J Med. 2010. PMID: 20818844 Free PMC article. Clinical Trial.
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Steffens TA, Bajorin DF, Chapman PB, Lovett DR, Cody-Johnson BV, Templeton MA, Heelan RT, Wong GY, Portlock CS, Oettgen HF, et al. Steffens TA, et al. Among authors: chapman pb. Cancer. 1991 Sep 15;68(6):1230-7. doi: 10.1002/1097-0142(19910915)68:6<1230::aid-cncr2820680608>3.0.co;2-q. Cancer. 1991. PMID: 1873774 Clinical Trial.
Medical treatment of metastatic melanoma.
Houghton AN, Meyers ML, Chapman PB. Houghton AN, et al. Among authors: chapman pb. Surg Clin North Am. 1996 Dec;76(6):1343-54. doi: 10.1016/s0039-6109(05)70519-3. Surg Clin North Am. 1996. PMID: 8977555 Review.
193 results